What Is CorMedix Inc. (CRMD) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, CorMedix Inc.'s intrinsic value is estimated at $5.25. Trading at its current price of $8.27, the valuation engine raises significant caution: 9 of 12 models flag downside risk, projecting an average implied return of -36.5%. The most optimistic model, RCMH-DCF, places fair value at $18.99 (+129.7%), while First Chicago — the most conservative — estimates $0.94 (-88.6%). This +218.3% gap reflects genuine analytical uncertainty about CorMedix Inc.'s intrinsic worth.
What Do the Models Say About CRMD?
12 of 13 models are currently active for CRMD. Of these, 3 models suggest upside while 9 models suggest overvaluation. The Bayesian DCF estimates CRMD's intrinsic value at $2.87, implying -65.3% downside from the current price. See which stocks rank higher →
How Does CRMD Rank in Pharmaceutical Preparations?
Among 469 Pharmaceutical Preparations stocks, CRMD ranks #71 by Quality of Company score. CirclFi's QOC score of 6.8/10 evaluates 32 fundamental signals. A score of 6.8 indicates above-average quality.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to pharmaceutical industry businesses. For CorMedix Inc., metrics like patent cliff exposure provide important context that general-purpose valuation models may underweight.
Is CRMD a Value Trap?
CirclFi's Value Trap algorithm assigns CRMD a score of 31/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for CorMedix Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, CorMedix Inc. scores 6.8 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +218.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CRMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CRMD's 12 active models, average confidence is 31%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad